ANIPライブシグナル | Getagraph.comで利益を最大化

売る 108089 min ago

@ $56.01

発行日: 15 2月 2024 @ 00:10

リターン: 17.39%

前回のシグナル: 2月 13 - 23:30

前回のシグナル: 買う

リターン: -0.01 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:28):

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada...

Stats
本日の出来高	12 299.00
平均出来高	144 911
時価総額	1.38B
EPS	$0 ( 2024-02-29 )
次の収益日	( $0 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	77.35
ATR14	$0.103 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Shanmugam Muthusamy	Sell	10 423	Common Stock
2024-04-19	Shanmugam Muthusamy	Sell	16 809	Common Stock
2024-04-15	Shanmugam Muthusamy	Sell	7 414	Common Stock
2024-04-16	Shanmugam Muthusamy	Sell	5 834	Common Stock
2024-04-17	Shanmugam Muthusamy	Sell	9 520	Common Stock

INSIDER POWER
-32.44
Last 100 transactions
Buy: 351 092 \| Sell: 732 643

ボリューム相関

長: -0.29 (neutral)

短: -0.79 (moderate negative)

Signal:(62.351) Neutral

ANI Pharmaceuticals Inc 相関

10 最も正の相関
LFMDP	0.941
BELFB	0.929
BELFA	0.926
IMTX	0.925
RAVE	0.919
PKOH	0.917
WRLD	0.915
MRAM	0.912
CNCE	0.912
SPNS	0.911

10 最も負の相関
ASO	-0.899
PMTS	-0.891
PAYS	-0.881
NLSP	-0.876
KPTI	-0.872
AY	-0.869
CDAK	-0.865
IVAC	-0.859
OBNK	-0.858
JRJC	-0.857

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

ANI Pharmaceuticals Inc 相関 - 通貨/商品

-0.37
( neutral )

0.31
( neutral )

0.00
( neutral )

-0.11
( neutral )

-0.02
( neutral )

0.50
( neutral )

ANI Pharmaceuticals Inc 財務諸表

Annual	2023
収益:	$486.82M
総利益:	$245.51M (50.43 %)
EPS:	$0.950

FY	2023
収益:	$486.82M
総利益:	$245.51M (50.43 %)
EPS:	$0.950

FY	2022
収益:	$316.39M
総利益:	$177.60M (56.13 %)
EPS:	$-2.95

FY	2021
収益:	$216.14M
総利益:	$115.53M (53.45 %)
EPS:	$-5.81

Financial Reports:

No articles found.

ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.